Literature DB >> 7961553

Substance abuse and clozapine treatment.

P Buckley1, P A Thompson, L Way, H Y Meltzer.   

Abstract

Among 118 patients with DSM-III-R diagnoses of schizophrenia or schizoaffective disorder who received treatment with clozapine, 29 patients had an antecedent or current history of substance abuse. Substance abusers and nonabusers showed similar improvements on measures of psychopathology and psychosocial functioning after 6 months of clozapine therapy. The implications of this finding are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7961553

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  3 in total

Review 1.  [Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].

Authors:  T Wobrock; R D'Amelio; P Falkai
Journal:  Nervenarzt       Date:  2008-01       Impact factor: 1.214

2.  Blinding in clozapine trials: a problem and a potential solution.

Authors:  Tamar Wohlfarth; Don Linszen; Wim Van Den Brink
Journal:  Int J Methods Psychiatr Res       Date:  2009-09       Impact factor: 4.035

Review 3.  What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients.

Authors:  Angelo G I Maremmani; Matteo Pacini; Icro Maremmani
Journal:  Int J Environ Res Public Health       Date:  2019-02-03       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.